Non-Viral Related Liver Enzymes Elevation After Kidney Transplantation

Authors

Behzad Einollahi1,*, Alireza Ghadian1, Ebrahim Ghamar-Chehreh2, Seyed Moayed Alavian3
1Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
2Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
3Middle East Liver Diseases Center (MELD), Tehran, IR Iran
*Corresponding Author: Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran. Tel/Fax: +98-2188934125, [email protected]. Email: [email protected]

Hepatitis Monthly:Vol. 14, issue 2; 9036
Published online:Feb 04, 2014
Article type:Research Article
Received:Nov 06, 2012
Accepted:Sep 30, 2013
How to Cite:Einollahi B, Ghadian A, Ghamar-Chehreh E, Alavian SM. Non-Viral Related Liver Enzymes Elevation After Kidney Transplantation. Hepat Mon. 2014;14(2):9036. doi: https://doi.org/10.5812/hepatmon.9036

Abstract

Background:

Liver enzymes elevations (LEE) can be observed after kidney transplantation due to multifactorial causes.

Objectives:

We performed a retrospective study on 1589 kidney transplants, 971 male and 618 female, who were hepatitis B surface antigen (HBsAg) and hepatitis C virus-antibody (HCV Ab) negative, and had no other liver diseases, to detect the prevalence of LEE and its risk factors in these patients between May 2008 and May 2010.

Patients and methods:

Liver enzymes and other biochemical parameters were measured in all recipients. Patients were divided into three groups, according to laboratory test time since transplantation: Group I, less than 3 months, Group II, 4 - 12 months after transplantation, and Group III, more than one year post-transplantation.

Results:

The highest LEE was more frequent in older patients (P < 0.001) and male individuals (P < 0.001). Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels were higher in patients who received kidneys from deceased donors (10.4% and 23.8%, respectively) as compared to living donor transplants (5.6% and 14.8%, respectively) (P < 0.001). The elevation of ALT was the liver enzyme abnormality after kidney transplantation with the highest prevalence (34.3%). The levels of ALT and AST were significantly elevated within the first 3 months after transplantation, followed by the 4-12 months period (P < 0.001). There was a reverse correlation between liver enzyme levels and renal allograft function in both univariate and linear regression analyses. This correlation increased over time. There was also a significant relation between cyclosporine blood levels and liver enzyme values in the univariate analysis. However, this relationship was attenuated over time. Elevated liver enzymes also correlated with anemia.

Conclusions:

The LEE is a common finding among kidney transplant recipients. Serial monitoring of aminotransferases, particularly ALT, should be performed in all patients after kidney transplantation.

Full Text

Full text is available in PDF

Copyright

© 2014, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

8
Oct
2016

Transplantation of Deceased Donor Livers With Elevated Levels of Serum Transaminases at Shiraz Transplant Center

Nasir Fakhar,
Saman Nikeghbalian,
Kourosh Kazemi,
Ali Reza Shamsayeefar,
Siavash Gholami,
Amir Kasraianfard
,et al.

Fakhar N, Nikeghbalian S, Kazemi K, Shamsayeefar AR, Gholami S, et al. Transplantation of Deceased Donor Livers With Elevated Levels of Serum Transaminases at Shiraz Transplant Center. Hepat Mon. 2016;16(10):e40140. doi: https://doi.org/10.5812/hepatmon.40140

16
Nov
2020
Evaluation of Liver Enzymes in End-Stage Renal Disease Patients on the Renal Transplant-Waiting List in North-West of Iran

Evaluation of Liver Enzymes in End-Stage Renal Disease Patients on the Renal Transplant-Waiting List in North-West of Iran

Samaneh Sabouri,
Monavar Afzal Aghaee,
Zahra Lotfi,
Habibollah Esmaily,
Maryam Alizadeh,
Hooman Mosannen Mozafari

Sabouri S, Afzal Aghaee M, Lotfi Z, Esmaily H, Alizadeh M, et al. Evaluation of Liver Enzymes in End-Stage Renal Disease Patients on the Renal Transplant-Waiting List in North-West of Iran. Nephro-Urol Mon. 2020;12(4):e107859. doi: https://doi.org/10.5812/numonthly.107859

27
Jul
2025
Latent Tuberculosis Management in Liver Transplant Recipients: Insights from a Retrospective Analysis

Latent Tuberculosis Management in Liver Transplant Recipients: Insights from a Retrospective Analysis

Mohsen Aliakbarian,
Mahboobeh Ghasemzadeh Rahbardar,
Zeinab Barzegar Torghabeh,
Gholamhossein Faghani,
Rozita Khodashahi

Aliakbarian M, Ghasemzadeh Rahbardar M, Barzegar Torghabeh Z, Faghani G, Khodashahi R. Latent Tuberculosis Management in Liver Transplant Recipients: Insights from a Retrospective Analysis. Arch Clin Infect Dis. 2025;20(5):e158129. doi: https://doi.org/10.5812/archcid-158129

23
Jun
2015

Correlation of Histopathologic Findings of Non-Graft Threatening Preservation/Reperfusion Injury in Time-Zero Liver Needle Biopsies With Short-Term Post-transplantation Laboratory Alterations

Narges Shahbazi,
Hayedeh Haeri,
Mohsen Nasiri Toosi,
Ali Jafarian,
Reza Shahsiah,
Monavar Talebian Moghadam
,et al.

Shahbazi N, Haeri H, Nasiri Toosi M, Jafarian A, Shahsiah R, et al. Correlation of Histopathologic Findings of Non-Graft Threatening Preservation/Reperfusion Injury in Time-Zero Liver Needle Biopsies With Short-Term Post-transplantation Laboratory Alterations. Hepat Mon. 2015;15(6):e30008. doi: https://doi.org/10.5812/hepatmon.30008v2

13
Jun
2013

Dyslipidemia After Kidney Transplantation and Correlation With Cyclosporine Level

Mahboobeh-Sadat Hosseini,
Zohreh Rostami,
Behzad Einollahi

Hosseini M, Rostami Z, Einollahi B. Dyslipidemia After Kidney Transplantation and Correlation With Cyclosporine Level. Nephro-Urol Mon. 2013;5(3):. doi: https://doi.org/10.5812/numonthly.11890

More by these authors

Behzad EinollahiPubMedScholar
Alireza GhadianPubMedScholar
Ebrahim Ghamar-ChehrehPubMedScholar
Seyed Moayed AlavianPubMedScholar
Share
Cited by
Metrics